As a leading provider of preclinical research services, Protheragen is committed to providing one-stop solutions for rare disease diagnostic development. Our expertise spans the development of in vitro diagnostic (IVD) reagents/kits, IVD devices, point-of-care testing (POCT) and companion diagnostics, ensuring customized and innovative diagnostic tools to meet the needs of different customers.

Focusing on rare genetic, infectious, autoimmune and metabolic diseases, Protheragen specializes in developing multiple types of IVD reagents/kits, including antigen, antibody, nucleic acid, metabolite and microbial detection products. Our diagnostic development follows a strict standardized workflow to ensure accuracy, reliability and compliance at every stage from design to validation.